Literature DB >> 23852711

Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association.

Anna Maria De Gaetano1, Erida Nure, Ugo Grossi, Francesco Frongillo, Rosellina Russo, Fabio Maria Vecchio, Maria Carmen Lirosi, Gabriele Sganga, Carla Felice, Lorenzo Bonomo, Salvatore Agnes.   

Abstract

Fibrolamellar hepatocellular carcinoma (FHCC) is a rare malignant tumor of hepatocyte origin occurring earlier in life than typical hepatocellular carcinoma (HCC). We describe a distinctive case of FHCC with biliary tumor thrombus (BTT) in a 25-year-old Caucasian patient, pointing out the imaging features supported by histopathology.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23852711     DOI： 10.1007/s11604-013-0233-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  23 in total

1.  Fine-needle aspiration cytology and differential diagnoses of fibrolamellar hepatocellular carcinoma metastatic to the mediastinum: case report.

Authors:  Venetia R Sarode; Rudy Castellani; Anthony Post
Journal:  Diagn Cytopathol       Date:  2002-02       Impact factor: 1.582

2.  Fibrolamellar hepatocellular carcinoma presenting with obstructive jaundice. A report of two cases.

Authors:  P Soyer; A Roche; M Levesque
Journal:  Eur J Radiol       Date:  1991 Nov-Dec       Impact factor: 3.528

3.  Best cases from the AFIP: fibrolamellar hepatocellular carcinoma.

Authors:  Mitchell T Smith; Ellen R Blatt; Paul Jedlicka; John D Strain; Laura Z Fenton
Journal:  Radiographics       Date:  2008 Mar-Apr       Impact factor: 5.333

Review 4.  Fibrolamellar hepatocellular carcinoma.

Authors:  Shu Liu; Kwok Wah Chan; Bingyuan Wang; Liang Qiao
Journal:  Am J Gastroenterol       Date:  2009-07-28       Impact factor: 10.864

5.  Imaging of fibrolamellar hepatocellular carcinoma.

Authors:  D J Brandt; C D Johnson; D H Stephens; L H Weiland
Journal:  AJR Am J Roentgenol       Date:  1988-08       Impact factor: 3.959

6.  Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

Authors:  Luigi Grazioli; Giovanni Morana; Miles A Kirchin; Günther Schneider
Journal:  Radiology       Date:  2005-06-13       Impact factor: 11.105

Review 7.  Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.

Authors:  J K McLarney; P T Rucker; G N Bender; Z D Goodman; N Kashitani; P R Ros
Journal:  Radiographics       Date:  1999 Mar-Apr       Impact factor: 5.333

8.  Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases.

Authors:  T Ichikawa; M P Federle; L Grazioli; J Madariaga; M Nalesnik; W Marsh
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

9.  Fibrolamellar hepatoma.

Authors:  D M Nagorney; M A Adson; L H Weiland; C D Knight; S R Smalley; A R Zinsmeister
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

10.  Primary non-Hodgkin's lymphoma of the main hepatic duct junction.

Authors:  Masaya Shito; Toshihiro Kakefuda; Tai Omori; Seiichiro Ishii; Hitoshi Sugiura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-08-01
View more
  2 in total

1.  A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus.

Authors:  Anon Chotirosniramit; Akkaphod Liwattanakun; Worakitti Lapisatepun; Wasana Ko-Iam; Trichak Sandhu; Sunhawit Junrungsee
Journal:  J Hepatocell Carcinoma       Date:  2017-03-07

2.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.